MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermosilla, R.
Right arrow Articles by Schülein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermosilla, R.
Right arrow Articles by Schülein, R.

Vol. 60, Issue 5, 1031-1039, November 2001

Sorting Functions of the Individual Cytoplasmic Domains of the G Protein-Coupled Vasopressin V2 Receptor in Madin Darby Canine Kidney Epithelial Cells

Ricardo Hermosilla and Ralf Schülein

Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany

Previous studies have shown that the G protein-coupled human vasopressin V2 receptor (V2 receptor) is expressed predominantly in the basolateral membrane of Madin Darby canine kidney type II (MDCKII) epithelial cells at steady state. Here we have assessed the influence of the individual cytoplasmic domains of the V2 receptor on polarized sorting in MDCKII cells. The second (ICL2) and third (ICL3) intracellular loops and the C-terminal tail were fused separately to a green fluorescent protein-tagged receptor fragment comprising the first transmembrane domain and flanking regions. We show that the ICL2 domain of the V2 receptor alone promotes basolateral cell surface expression and thus seems to contain the basolateral sorting signal of the V2 receptor. Fusion of the other cytoplasmic domains, however, does not lead to a randomized cell surface expression. The C-terminal tail of the V2 receptor promotes apical targeting. Fusion of ICL3 leads to a receptor fragment that is retained in the endoplasmic reticulum (ER). The results are consistent with a model in which the V2 receptor contains signals for both apical and basolateral cell surface expression, the latter being dominant. Furthermore, ICL3 may contain a retinoid X receptor ER retention signal, which is not accessible in the correctly folded full-length receptor but which is unmasked when ICL3 is fused alone.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
N. F. Berbari, A. D. Johnson, J. S. Lewis, C. C. Askwith, and K. Mykytyn
Identification of Ciliary Localization Sequences within the Third Intracellular Loop of G Protein-coupled Receptors
Mol. Biol. Cell, April 1, 2008; 19(4): 1540 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Arniges, J. M. Fernandez-Fernandez, N. Albrecht, M. Schaefer, and M. A. Valverde
Human TRPV4 Channel Splice Variants Revealed a Key Role of Ankyrin Domains in Multimerization and Trafficking
J. Biol. Chem., January 20, 2006; 281(3): 1580 - 1586.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. Bouley, H. Y. Lin, M. K. Raychowdhury, V. Marshansky, D. Brown, and D. A. Ausiello
Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1390 - C1401.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Wuller, B. Wiesner, A. Loffler, J. Furkert, G. Krause, R. Hermosilla, M. Schaefer, R. Schulein, W. Rosenthal, and A. Oksche
Pharmacochaperones Post-translationally Enhance Cell Surface Expression by Increasing Conformational Stability of Wild-type and Mutant Vasopressin V2 Receptors
J. Biol. Chem., November 5, 2004; 279(45): 47254 - 47263.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
I. Beau, M.-T. Groyer-Picard, A. Desroches, E. Condamine, J. Leprince, J.-P. Tome, P. Dessen, H. Vaudry, and M. Misrahi
The Basolateral Sorting Signals of the Thyrotropin and Luteinizing Hormone Receptors: An Unusual Family of Signals Sharing an Unusual Distal Intracellular Localization, but Unrelated in Their Structures
Mol. Endocrinol., March 1, 2004; 18(3): 733 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. Bouley, T.-X. Sun, M. Chenard, M. McLaughlin, M. McKee, H. Y. Lin, D. Brown, and D. A. Ausiello
Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C750 - C762.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Oksche, G. Leder, S. Valet, M. Platzer, K. Hasse, S. Geist, G. Krause, A. Rosenthal, and W. Rosenthal
Variant Amino Acids in the Extracellular Loops of Murine and Human Vasopressin V2 Receptors Account for Differences in Cell Surface Expression and Ligand Affinity
Mol. Endocrinol., April 1, 2002; 16(4): 799 - 813.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics